Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies. [electronic resource]
Producer: 20040120Description: 524-30 p. digitalISSN:- 0022-538X
- Antibodies, Monoclonal -- pharmacology
- CD4 Antigens -- metabolism
- Chemokine CCL5 -- pharmacology
- Chemokine CXCL12
- Chemokines, CC -- pharmacology
- Chemokines, CXC -- pharmacology
- Disease Progression
- HIV Envelope Protein gp120 -- chemistry
- HIV Infections -- immunology
- HIV-1 -- drug effects
- Humans
- Mutation
- Neutralization Tests
- Peptide Fragments -- genetics
- Receptors, CCR5 -- metabolism
- Receptors, CXCR4 -- metabolism
- Solubility
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.